Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Trans people have often been denied treatment in Pakistan because doctors could not decide whether to treat them in a male or female ward, and have even died for lack of care. The government plans to set up separate wards in hospitals around the country for transgender patients, according to Dr. Zafar Mirza, a special aide to Prime Minister Imran Khan for health services. Pakistan a conservative, majority Muslim nation officially recognized transgender as a third gender in 2012. Yet transgender people are still largely confined to the margins of society, often taunted in public, ostracized by family and targeted in violent attacks. Most transgender people in Pakistan are forced to survive by begging, dancing or prostitution. Sex reassignment surgery requires a court order, family approval, a psychiatrist's note and a medical recommendation. The Supreme Court ordered the government to list transgender as a third gender on ID cards, and the national agency responsible for issuing them will also handle the new health cards. The health ministry will immediately start giving health cards to all transgender people who are registered, said Dr. Mirza. He said anyone who wants to change the listing on their ID to transgender will have a "one-time option" to do so. He didn't specify how long that period would last. Speaking to reporters in the capital of Islamabad, he stressed that the government is legally responsible for ensuring all citizens' rights, including access to healthcare nationwide. Transgender people face greater peril in more conservative areas of Pakistan, where Islamic extremists associate them with homosexuality and prostitution. But there are also signs of progress. In 2018, Marvia Malik made history by becoming Pakistan's first transgender newscaster at just 21 years old. ____ Khan reported from Karachi, Pakistan
Pakistan issues health IDs for trans people to improve care.

The Health Department said Wednesday that different variations of the virus are circulating in different parts of the state. The agency says 21 pneumonia and flu deaths have been reported so far this season. Last season, 237 New Mexicans died of pneumonia and/or influenza. Symptoms may include rapid onset of illness with fever, cough, sore throat, headache and/or muscle aches. New Mexico Health Secretary Kathyleen Kunkel says with the holidays approaching, it's important that people take preventive measures such as getting vaccinated, covering coughs and staying home when sick. Officials say the peak of the flu season is still to come.
Health officials: Flu activity widespread in New Mexico.

"The two drugs work through different mechanisms of action, but there is a synergistic effect that inhibits the growth of prostate cancer cells," said Xi Cheng, assistant research professor at Rutgers, the State University of New Jersey, who conducted the study. His team administered a combination of Celebrex, a non-steroidal anti-inflammatory drug used to treat arthritis and other pain, and Lipitor, a cholesterol lowering statin, to cultured mice tumors in order to measure the transition of early prostate cancer to its more aggressive and potentially fatal stage. Both drugs are sold by Pfizer Inc, but the company played no role in the National Institutes of Health-funded study, Zheng said. The researcher said both drugs have been shown in earlier studies to have some impact on cancer growth when used alone. The Rutgers team found that the combination of low doses of Lipitor and Celebrex had a more potent impact on tumor growth than a higher dose of either agent when used separately. Prostate cancer is the second-leading cause of cancer death in men in the United States, with more than a quarter-million new cases appearing each year, according to the American Cancer Society. In the early stage of the disease, prostate cancer cells depend on androgen hormones, such as testosterone, to grow. Treatment involves either decreasing the production of the hormone or blocking its action. "Anti-androgen therapy slows the prostate cancer but eventually the cancer becomes androgen-independent, the therapy becomes ineffective and the cancer cells become more aggressive," said Zheng. "Treatments available for the later stage cancers are not very good," Allan Conney, director of cancer research at Rutgers, said in a statement. "Oncologists employ classical chemotherapy drugs which are very toxic and don't work all that well." The objective of the Rutgers study was to indefinitely delay the transition to androgen-independence, prolonging the time during which the cancer would be responsive to low-toxicity, anti-hormone therapy. Zheng said it appears that a cell signaling pathway for tumor cell growth is inhibited by the combination of the two compounds. He said human clinical trials are being planned.
Celebrex-Lipitor combo may fight prostate cancer.